Anti-alarmin asthma therapies: where do we go from here?

J Bras Pneumol. 2023 Jul 24;49(3):e20230220. doi: 10.36416/1806-3756/e20230220.

[Article in English, Portuguese]

Authors

Ibrahim Sulaiman¹, Gail M Gauvreau²

Affiliations

¹ . Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, Bridgetown, Barbados.
² . Faculty of Health Sciences, McMaster University, Hamilton (ON) Canada.

No abstract available

Publication types

Editorial

MeSH terms

Alarmins / therapeutic use
Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Humans

Substances

Anti-Asthmatic Agents
Alarmins